NASDAQ:RANI

Rani Therapeutics Holdings Stock Forecast

etoro logo Buy RANI
*Your capital is at risk
$0.84
+0.0246 (+3.00%)
At Close: Jul 29, 2026
AI Analysis AI Analysis of RANI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RANI to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Rani Therapeutics Holdings, Inc. stock price up 3.00% on Wednesday
(Updated on Jul 29, 2026)

Buy or Hold candidate since Jul 22, 2026 Loss -5.89%

The Rani Therapeutics Holdings, Inc. stock price gained 3.00% on the last trading day (Wednesday, 29th Jul 2026), rising from $0.82 to $0.84. During the last trading day the stock fluctuated 9.94% from a day low at $0.791 to a day high of $0.87. The price has been going up and down for this period, and there has been a 24.65% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 361 thousand more shares were traded than the day before. In total, 702 thousand shares were bought and sold for approximately $592.32 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.87 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -26.64% during the next 3 months and, with a 90% probability hold a price between $0.418 and $0.639 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RANI Signals & Forecast

The Rani Therapeutics Holdings, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.83 and $0.756. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Rani Therapeutics Holdings, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 22, 2026, and so far it has fallen -5.89%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Rani Therapeutics Holdings, Inc. stock

Rani Therapeutics Holdings, Inc. finds support from accumulated volume at $0.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0786 between high and low, or 9.94%. For the last week, the stock has had daily average volatility of 10.37%.

Our recommended stop-loss: $0.798 (-5.47%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (RANI) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Rani Therapeutics Holdings, Inc. to open at $0.83, and during the day (based on 14 day Average True Range), to move between $0.81 and $0.88, which gives a possible trading interval of +/-$0.0716 (+/-8.87%) up or down from last closing price. If Rani Therapeutics Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 8.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.81 (3.87%) than the resistance at $0.90 (6.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Rani Therapeutics Holdings, Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0500. We will update the financials statements for Rani Therapeutics Holdings, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.76% in the first trading day after earnings release.

Is Rani Therapeutics Holdings, Inc. stock A Buy?

Rani Therapeutics Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.458 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $0.83 ( 1.07%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RANI Performance

Trading levels for RANI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.91 8.25%
R2 0.88 4.69%
R1 0.86 2.49%
Price 0.84
S1 0.80 -4.62%
S2 0.786 -6.82%
S3 0.756 -10.38%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.94 11.45%
R2 0.90 6.26%
R1 0.90 6.14%
Price 0.84
S1 0.81 -3.87%
S2 0.709 -15.95%
S3 0.697 -17.37%

FAQ

What is the symbol for Rani Therapeutics Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Rani Therapeutics Holdings, Inc. is RANI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rani Therapeutics Holdings, Inc. Stock?
Rani Therapeutics Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Rani Therapeutics Holdings, Inc. Stock?
Rani Therapeutics Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rani Therapeutics Holdings, Inc. Stock.

What's the current price of Rani Therapeutics Holdings, Inc. Stock?
As of the end of day on the Jul 29, 2026, the price of an Rani Therapeutics Holdings, Inc. (RANI) share was $0.84.

What is the 52-week high and low for Rani Therapeutics Holdings, Inc. Stock?
The 52-week high for Rani Therapeutics Holdings, Inc. Stock is $3.87 and the 52-week low is $0.440.

What is the market capitalization of Rani Therapeutics Holdings, Inc. Stock?
As of the Jul 29, 2026, the market capitalization of Rani Therapeutics Holdings, Inc. is 55.124M.

When is the next earnings date for Rani Therapeutics Holdings, Inc.?
The upcoming earnings date for Rani Therapeutics Holdings, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT RANI THERAPEUTICS HOLDINGS, INC.
Rani Therapeutics Holdings
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-al...
GOLDEN STAR
Ticker Change Signal Date
BIIB
$202.19
1.69% Jul 24
A
AVS
$7.74
0.388% Jul 24
IMMR
$6.60
16.06% Jul 23
S
SW
$43.71
16.22% Jul 23
TSCO
$30.32
3.76% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE